Alasdair Kennedy FRCOphth1, Jessica G Shantha2, Ji-Peng Olivia Li3, Lisa J Faia4, Caleb Hartley5, Sanjana Kuthyar2, Thomas A Albini6, Henry Wu7, James Chodosh8, Daniel S W Ting9, Steven Yeh2,10. 1. Brighton and Sussex Medical School, Brighton, United Kingdom. 2. Emory Eye Center, Emory University School of Medicine, Atlanta, GA. 3. Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom. 4. Associated Retinal Consultants, Royal Oak, MI. 5. Emory University Rollins School of Public Health, Atlanta, GA. 6. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. 7. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA. 8. Massachusetts Eye and Ear, Harvard Medical School, Boston, MA. 9. Singapore National Eye Center, Duke-NUS Medical School, Singapore. 10. Emory Global Health Institute, Emory University, Atlanta, GA.
Abstract
PURPOSE: The current SARS-CoV-2 pandemic has escalated rapidly since December 2019. Understanding the ophthalmic manifestations in patients and animal models of the novel coronavirus may have implications for disease surveillance. Recognition of the potential for viral transmission through the tear film has ramification for protection of patients, physicians, and the public. METHODS: Information from relevant published journal articles was surveyed using a computerized PubMed search and public health websites. We summarize current knowledge of ophthalmic manifestations of SARS-CoV-2 infection in patients and animal models, risk mitigation measures for patients and their providers, and implications for retina specialists. RESULTS: SARS-CoV-2 is efficiently transmitted among humans, and while the clinical course is mild in the majority of infected patients, severe complications including pneumonia, acute respiratory distress syndrome, and death can ensue, most often in elderly patients and individuals with co-morbidities. Conjunctivitis occurs in a small minority of patients with COVID-19 and SARS-CoV-2 RNA has been identified primarily in association with conjunctivitis. Uveitis has been observed in animal models of coronavirus infection and cotton-wool spots have been reported recently. CONCLUSION: SARS-CoV-2 and other coronaviruses have been rarely associated with conjunctivitis. The identification of SARS-CoV and SARS-CoV-2 RNA in the tear film of patients and its highly efficient transmission via respiratory aerosols supports eye protection, mask and gloves as part of infection prevention and control recommendations for retina providers. Disease surveillance during the COVID-19 pandemic outbreak may also include ongoing evaluation for uveitis and retinal disease given prior findings observed in animal models and a recent report of retinal manifestations.
PURPOSE: The current SARS-CoV-2 pandemic has escalated rapidly since December 2019. Understanding the ophthalmic manifestations in patients and animal models of the novel coronavirus may have implications for disease surveillance. Recognition of the potential for viral transmission through the tear film has ramification for protection of patients, physicians, and the public. METHODS: Information from relevant published journal articles was surveyed using a computerized PubMed search and public health websites. We summarize current knowledge of ophthalmic manifestations of SARS-CoV-2 infection in patients and animal models, risk mitigation measures for patients and their providers, and implications for retina specialists. RESULTS: SARS-CoV-2 is efficiently transmitted among humans, and while the clinical course is mild in the majority of infected patients, severe complications including pneumonia, acute respiratory distress syndrome, and death can ensue, most often in elderly patients and individuals with co-morbidities. Conjunctivitis occurs in a small minority of patients with COVID-19 and SARS-CoV-2 RNA has been identified primarily in association with conjunctivitis. Uveitis has been observed in animal models of coronavirus infection and cotton-wool spots have been reported recently. CONCLUSION: SARS-CoV-2 and other coronaviruses have been rarely associated with conjunctivitis. The identification of SARS-CoV and SARS-CoV-2 RNA in the tear film of patients and its highly efficient transmission via respiratory aerosols supports eye protection, mask and gloves as part of infection prevention and control recommendations for retina providers. Disease surveillance during the COVID-19 pandemic outbreak may also include ongoing evaluation for uveitis and retinal disease given prior findings observed in animal models and a recent report of retinal manifestations.
Authors: Esam I Azhar; Sherif A El-Kafrawy; Suha A Farraj; Ahmed M Hassan; Muneera S Al-Saeed; Anwar M Hashem; Tariq A Madani Journal: N Engl J Med Date: 2014-06-04 Impact factor: 91.245
Authors: Lan T Phan; Thuong V Nguyen; Quang C Luong; Thinh V Nguyen; Hieu T Nguyen; Hung Q Le; Thuc T Nguyen; Thang M Cao; Quang D Pham Journal: N Engl J Med Date: 2020-01-28 Impact factor: 91.245
Authors: Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai Journal: N Engl J Med Date: 2020-01-31 Impact factor: 91.245
Authors: Astrid Vabret; Thomas Mourez; Julia Dina; Lia van der Hoek; Stéphanie Gouarin; Joëlle Petitjean; Jacques Brouard; François Freymuth Journal: Emerg Infect Dis Date: 2005-08 Impact factor: 6.883
Authors: H J Lee; C K Shieh; A E Gorbalenya; E V Koonin; N La Monica; J Tuler; A Bagdzhadzhyan; M M Lai Journal: Virology Date: 1991-02 Impact factor: 3.616